- Pandox’s EBITDA for Q3 came in at SEK 1.12 billion, missing the estimate of SEK 1.16 billion.
- Income from property management was reported at SEK 1.07 billion.
- The company recorded a net loss of SEK 39 million, compared to a profit of SEK 460 million in the same period last year.
- Comments from the company indicate an expectation of Revenue Per Available Room (RevPAR) growth in the hotel market in 2025.
- Recently completed acquisitions and investments in the existing portfolio are expected to contribute positively to future results.
- Analyst recommendations include 3 buy ratings, 2 hold ratings, and 0 sell ratings.
“`
A look at Pandox AB Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analyzing the Smartkarma Smart Scores for Pandox AB, the company shows a promising long-term outlook. With a strong rating for Growth and Momentum, Pandox AB is positioned well for future expansion and market performance. The company’s focus on value and consistent growth potential aligns with its strategic investments in hotel properties, particularly in lucrative areas of northern Europe.
Pandox AB‘s emphasis on sustainable growth and active management of its hotel businesses contributes to its high scores in Growth and Momentum factors. Despite a lower rating in Resilience, the company’s proactive approach to property development and leasing enhances its overall outlook. Investors may find Pandox AB an attractive choice for long-term investment based on its solid foundation in owning and operating centrally located hotel properties in the region.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
